1. Home
  2. IRTC vs AMRX Comparison

IRTC vs AMRX Comparison

Compare IRTC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$113.49

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.22

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRTC
AMRX
Founded
2006
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
IRTC
AMRX
Price
$113.49
$17.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
5
Target Price
$197.92
$15.60
AVG Volume (30 Days)
620.1K
2.1M
Earning Date
04-30-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
61.71
157.89
EPS
N/A
0.19
Revenue
$747,138,000.00
N/A
Revenue This Year
$19.60
$4.48
Revenue Next Year
$15.94
$7.13
P/E Ratio
N/A
$90.68
Revenue Growth
26.24
N/A
52 Week Low
$100.85
$7.67
52 Week High
$210.01
$17.86

Technical Indicators

Market Signals
Indicator
IRTC
AMRX
Relative Strength Index (RSI) 45.69 66.10
Support Level $111.37 $16.45
Resistance Level $121.88 $17.86
Average True Range (ATR) 5.67 0.54
MACD -0.72 -0.14
Stochastic Oscillator 17.75 54.61

Price Performance

Historical Comparison
IRTC
AMRX

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: